Document:

atax-ex1049_661.htm

 

Exhibit 10.49

SUBSCRIPTION DOCUMENTS

INSTRUCTIONS TO INVESTORS

AFTER YOU HAVE DECIDED TO SUBSCRIBE FOR AND PURCHASE THE UNITS, PLEASE OBSERVE THESE INSTRUCTIONS:

 

	
A.
	
Confidential Subscriber Questionnaire
	
 
	
Complete and sign two originals of the "Confidential Subscriber Questionnaire." The purpose of the Confidential Subscriber Questionnaire is to provide information as to the suitability of subscribers pursuant to the requirements of the Securities Act of 1933, as amended, and the applicable state securities laws. It is understood that the information provided is confidential and will not be reviewed by anyone other than the Partnership, the General Partner, and its counsel, unless such disclosure is deemed by any such person to be necessary to establish any claim of exemption.

	
 
	
 
	
 
	
 

	
B.
	
Subscription Agreement
	
 
	
Complete and sign two originals of the "Subscription Agreement." PLEASE READ THE SUBSCRIPTION AGREEMENT IN ITS ENTIRETY. IT CONTAINS VARIOUS STATEMENTS AND REPRESENTATIONS TO BE MADE BY SUBSCRIBERS, AS WELL AS ADDITIONAL INFORMATION ABOUT THE PARTNERSHIP.

	
 
	
 
	
 
	
 

	
C.
	
Counterpart Signature Page to the LP Agreement
	
 
	
Complete and sign two originals of the counterpart signature page to the LP Agreement.

	
 
	
 
	
 
	
 

	
D.
	
Return of Subscription Materials
	
 
	
All of the foregoing documents must be delivered to:

	
 
	
 
	
 
	
 

	
 
	
 
	
 
	
 
	
America First Multifamily Investors, L.P. 

c/o The Burlington Capital Group LLC

1004 Farnam Street, Suite 400

Omaha, Nebraska 68102

Attention: Craig S. Allen, Chief Financial Officer

	
 
	
 
	
 
	
 

	
ALL INFORMATION IS TO BE TYPED OR PRINTED IN INK
	
 
	
After receipt of all the foregoing completed documents, the General Partner will determine whether to accept the subscription. If the subscription is accepted, the General Parmer will notify' the prospective investor of the date by which the prospective investor will be required to transmit the amount of such investor's subscription proceeds, together with instructions for making payment for the Units to be purchased. All payments must be made by wire transfer of immediately available funds. If a potential investor's subscription is not accepted, the General Partner will notify such potential investor as soon as practicable

Subscription Instructions

 

AMERICA FIRST MULTIFAMILY INVESTORS, L.P.

(A Delaware Limited Partnership)

Series A Preferred Units of Limited Partnership Interest

SUBSCRIPTION AGREEMENT

THIS SUBSCRIPTION AGREEMENT (the "Agreement") is effective as of the date set forth on the signature page hereof (the "Effective Date"), between the undersigned subscriber (the "Subscriber"), and AMERICA FIRST MULTIFAMILY INVESTORS, L.P., a Delaware limited partnership (the "Partnership").

RECITALS

WHEREAS, the Partnership is offering for sale 10,000,000 Series A Preferred Units of Limited Partnership Interests of the Partnership (the "Series A Preferred Units") at a price of $10.00 per unit (the "Offering”), with a minimum investment requirements of $5,000,000 (500,000 Series A Preferred Units) per subscriber, unless otherwise approved by the General Partner in its sole discretion; and

WHEREAS, the Series A Preferred Units are being offered by the Partnership pursuant to a Confidential Private Placement Memorandum dated December 1 8, 2015 (the "Memorandum"); and

WHEREAS, all capitalized terms not otherwise defined herein shall have the meanings set forth in the Memorandum.

NOW, THEREFORE, in consideration of the promises made by the parties herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows.

AGREEMENT

1.Subscription for Serie A Preferred Units. Subject to the terms and conditions of this Agreement, as of the Effective Date the Subscriber hereby subscribes for, and the Partnership agrees to issue to the Subscriber, that number of Series A Preferred Units of the Partnership set forth on the Subscriber's signature page hereto.

2.Series A Preferred Units Not Registered. The Subscriber understands that an investment in the Series A Preferred Units involves a high degree of risk and it suitable only for sophisticated purchasers who have such knowledge and experience in financial and business matters and who are capable of evaluating the merits and risks of an investment in the Series A Preferred Units. The Subscriber understands that the Series A Preferred Units have not been registered under the Securities Act of 1933, as amended (the “1933 Act”), or the securities, "blue sky," or other similar law of any state, in each case in reliance upon exemptions from registration provided under the 1933 Act, including but not limited to Section 4(a)(2) of the 1933 Act and Regulation D adopted by the Securities and Exchange Commission, as well as specific exemptions under state securities, "blue sky," and other similar laws.

3.Representations and Warranties. The Subscriber understands that the Partnership is relying upon the representations and agreements contained in this Agreement (and any supplemental information) for the purpose of determining whether this transaction meets the requirements for the exemptions set forth in Section 2 above. Accordingly, the Subscriber hereby represents and warrants to the Partnership, and intends that the Partnership rely upon these representations and warranties for the purpose of establishing the acceptability of this Agreement, as follows:

(a)Subscriber Information. The address of the Subscriber in the Confidential Subscriber Questionnaire accompanying this Agreement is the true and correct address of the domicile and residency of the Subscriber, and the Subscriber has no present intention of changing such address to another state or jurisdiction. The Subscriber agrees to promptly notify the Partnership if the information contained in this Agreement, the accompanying Confidential Subscriber Questionnaire, or any other document is or becomes incorrect.

 

Subscription Instructions

 

(b)Investment Intent. The Subscriber is subscribing for the Series A Preferred Units for its own account and for investment purposes only, and not with a view to the distribution or resale thereof, in whole or in part, to anyone else.

(c)Transfer Restrictions; Liquidity. The Subscriber acknowledges that the transferability of the Series A Preferred Units is severely limited and that the Subscriber must continue to bear the economic risk of this subscription for an indefinite period as the Series A Preferred Units have not been registered under the 1933 Act or under any other state securities laws, and therefore cannot be offered or sold unless they are subsequently registered under such acts or an exemption from such registration is available and the Subscriber has obtained an opinion of counsel satisfactory to the General Partner that such registration is not required in connection with any such transaction. The Subscriber is in such a financial condition that it has no need for liquidity with respect to a subscription in the Series A Preferred Units and no need to dispose of any portion of the Series A Preferred Units subscribed for hereby to satisfy any existing or contemplated undertaking or indebtedness. The Subscriber hereby represents that, at the present time, the Subscriber could afford a complete loss of its subscription in the Series A Preferred Units.

(d)No Governmental Approvals of Offering. The Subscriber understands that no federal or state governmental agency or authority has passed upon the Series A Preferred Units or made any finding or determination concerning the fairness, advisability, or merits of this subscription.

(e)Availability of Other Information. The Subscriber acknowledges that the Partnership has made available to it and its management the opportunity to ask questions and receive answers concerning the Partnership, the LP Agreement, and the Series A Preferred Units, and to obtain any additional information which the Partnership or General Partner possesses or can acquire without unreasonable effort or expense and has received any and all information requested.

(f)Independent Evaluation of Subscription. No representations or warranties have been made to the Subscriber concerning the Partnership, its business, or the Series A Preferred Units by die Partnership, the General Partner, any affiliate of the Partnership or the General Partner, or any agent, officer, or employee of any of them, or by any other person, and in entering into this Agreement the Subscriber is not relying on any information other than the results of the Subscriber's own independent investigation and due diligence. In this regard, the Subscriber has made its own inquiry and analysis (on its own or with the assistance of others) with respect to the Partnership and its business, the Series A Preferred Units, the LP Agreement, and other material factors affecting the Series A Preferred Units. Based on such information and analysis, the Subscriber has been able to make an informed decision to subscribe for the Series A Preferred Units.

(g)Sophistication of Subscriber. The Subscriber has such knowledge and experience in financial and business matters that the Subscriber is capable of evaluating the merits and risks of a subscription in the Series A Preferred Units. To the extent necessary, the Subscriber has retained, at its own expense, and relied upon, appropriate professional advice regarding the investment, tax, and legal merits and consequences of this subscription and ownership of the Series A Preferred Units.

(h)No Public Market for the Series A Preferred Units. The Subscriber understands that there is no public market for the Series A Preferred Units and such a public market is unlikely ever to develop.

(i)State of Domicile. The Subscriber's state of domicile, both at the time of the initial offer of the Series A Preferred Unit’s to the Subscriber and at the present time, was and is within the state set forth in the Subscriber's address disclosed on this Agreement below.

 

Subscription Agreement

2-

 

(j)Subscriber Status. The Subscriber understands that the Series A Preferred Units are being offered by the Company only to the Subscriber and not to the public at large. By executing this Agreement, the Subscriber hereby represents that the representations and warranties of the Subscriber set forth in the Confidential Subscriber Questionnaire attached to this Agreement are true and correct.

(k)Entity Representations. The Subscriber hereby represents that the Subscriber's governing instruments permit, and it is duly qualified to make, this subscription for the Series A Preferred Units and that the execution and delivery of this Agreement and the LP Agreement of the Partnership have been duly authori7ßd by all required corporate action.

(l)Tax Consequences of Subscription. The Subscriber hereby acknowledges that there can be no assurance regarding the tax consequences of a subscription for the Series A Preferred Units, nor can there be any assurance that the Internal Revenue Code of 1986, as amended, or the regulations promulgated thereunder, or other applicable laws and regulations, will not be amended at some future time. In making this subscription for the Series A Preferred Units, the Subscriber hereby represents that it is relying solely upon the advice of the Subscriber's tax advisor with respect to the tax aspects of a subscription for the Series A Preferred Units.

(m)Anti-Money Laundering Provisions. Neither the Subscriber nor (i) any person controlling or controlled by the Subscriber, (ii) any person having a beneficial interest in the Subscriber, or (iii) any person for whom the Subscriber is acting as agent or nominee in connection with this investment, is a person or entity with which the Partnership would be prohibited from engaging in a transaction under the rules and regulations administered by the U.S. Treasury Department's Office of Foreign Assets Control, No funds the Subscriber will use for the purchase of Series A Preferred Units either now or for any future capital contributions, if any, were, and are not directly or indirectly derived from, activities that contravene U.S. federal, state, local, or international laws and regulations applicable to the Subscriber, including U.S. anti-money laundering laws and regulations. The Subscriber agrees to promptly notify the Partnership if any of the foregoing representations in this Section 3(m) cease to be true and accurate regarding the Subscriber. The Subscriber also agrees to provide the Partnership and the General Partner with any additional information regarding the Subscriber that the Partnership or General Partner deems necessary or convenient to ensure compliance with the foregoing representations. The Subscriber understands and agrees that if at any time it is discovered that any of the foregoing representations are incorrect, or if otherwise required by applicable law or regulation related to money laundering or similar activities, the Partnership may undertake appropriate actions to ensure compliance with applicable laws or regulations, including, but not limited to, segregation and/or redemption of the Subscriber's investment in the Series A Preferred Units. The Subscriber further understands that the Partnership may release confidential information about the Subscriber and, if applicable, any underlying beneficial owners of the Subscriber, to the proper authorities if the General Partner, in its sole discretion, determines that it is in the best interests of the Partnership in light of the foregoing described anti-money laundering rules.

(n)No Right to Require Registration. The Subscriber understands that the Subscriber has no right to require the Partnership to register the Series A Preferred Units under federal or state securities laws at any time,

4.Other Covenants.

(a)Governing Law. The Subscriber agrees that, notwithstanding the place where this Agreement may be executed by any of the parties hereto, all the terms and provisions hereof shall be construed in accordance with and governed by the laws of the State of Delaware, without regard to principles of conflicts of laws. The Subscriber hereby irrevocably agrees that any suit, action, or proceeding with respect to this Agreement and any or all transactions relating hereto shall be brought in the local courts in New Castle County, Delaware or in the U.S. District Court for the District of Delaware, as the case may be.

 

Subscription Agreement

 

 

(b)Indemnification of the Company and Others. The Subscriber agrees to hold the Partnership, the General Partner, and its officers managers, and controlling persons (as defined in the 1933 Act), and any persons affiliated with any of them or with the issuance of the Series A Preferred Units, harmless from all expenses, liabilities, and damages (including reasonable attorneys' fees) deriving from a disposition of the Series A Preferred Units by the Subscriber in a manner in violation of the 1933 Act, or of any applicable state securities law or which may be suffered by any such person by reason of any breach by the Subscriber of any of the representations contained herein.

(c)No Commissions. No person will receive any remuneration in connection with the offer, sale, or issuance of the Series A Preferred Units.

5.Amendments. Neither this Agreement nor any term hereof may be amended, changed, or waived without the prior written consent of all the parties hereto.

6.Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original but all of which taken together shall constitute one and the same Agreement.

7.Legend. The Subscriber acknowledges and agrees that the Partnership may, in the event it deems the same desirable to assure compliance with applicable federal and state securities laws, place an appropriate restrictive legend upon any certificate representing the Series A Preferred Units issued pursuant to this Agreement.

8.Entire Agreement. This Agreement contains the entire agreement and understanding of the parties with respect to its subject matter and supersedes all prior agreements and understandings between the parties with respect to their subject matter.

9.Miscellaneous. This Agreement is not transferable or assignable by the Subscriber. All notices or other communications to be given or made hereunder to the Subscriber shall be in writing and may be hand delivered or sent by fax, certified or registered mail, postage prepaid, e-mail, or by a private overnight delivery service to the Subscriber's address set forth below.

[Signature page follows]

 

Subscription Agreement

4-

 

IN WITNESS WHEREOF, the parties have executed this Subscription Agreement to be effective as of the Effective Date set forth below.

 

	
SUBSCRIBER:
	
 
	
 

	
 
	
 
	
 

	
Name of Subscriber:
	
 
	
Pacific Premier Bank

	
 
	
 
	
 

	
Address of Subscriber: 
	
 
	
17901 Von Karman Avenue, Suite 1200, Irvine, CA, 92614

	
 
	
 
	
 

	
Signature and Title of Authorized Person:  
	
 
	
Eddie Wilcox, President & Chief Banking Officer

	
 
	
 
	
 

	
Number of Series A Preferred Units Subscribed For:
	
 
	
700 000

	
 
	
 
	
 

	
Aggregate Amount of Subscription: 
	
 
	
$7.000.000

	
 
	
 
	
 

	
Date Signed:
	
 
	
December 1, 2016

 

SELECTION OF DESIGNATED TARGET REGION:

The Subscriber indicated above hereby selects the following as the Designated Target Region for the Subscriber's investment:

Complete One:

 

		
	
The State of California
	
 

	
The multi-state region including
	
 

	
The metropolitan area of
	
 

	
The entire United States.
	
 

 

The Subscriber also may specify the amount of the Subscriber's investment proceeds to be allocated to one or more of the following Specified CRA Assets:

As noted below.

	
	
 

	
 

The Subscriber may also request an allocation of capital to specific investments already within the portfolio. Such requests to be allocated as according to the "CRA Credit Allocation Methodology" set forth in the PPM and subject to confirmation by the General Partner.

 

	
Name
	
Las Palmas II
	
Courtyard
	
Seasons at San Juan Capistrano

	
Street Address
	
51075 Frederick Street
	
4127 W Valencia Dr.
	
31641 Rancho Viejo Road

	
City, State, Zip
	
Coachella, CA 92236
	
Fullerton, CA 92833
	
San Juan Capistrano, 92675

	
County
	
Riverside
	
Orange
	
Orange

	
Allocation Request
	
$1,695,000
	
$2,305,000
	
$3,000,000

 

By signing this Agreement, the Subscriber acknowledges reading and agrees to the provisions set forth in the section captioned "CRA Credit Allocation Methodology of the Memorandum. The Subscriber acknowledges that the General Partner provides no guarantee that the Subscriber will receive CRA credit for its investment in the Series A Preferred Units.

 

Subscription Agreement

 

 

SUBSCRIPTION ACCEPTANCE

This Subscription Agreement is accepted as of December 1, 2016.

 

		
	
AMERICA FIRST MULTIFAMILY 

INVESTORS, L.P.

	
By:
	
America First Capital Associates Limited

	
 
	
Partnership Two, its General Partner

	
By:
	
The Burlington Capital Group LLC, its General

	
 
	
Partner

	
By:
	
/s/ Lisa Y. Roskens

	
 
	
Lisa Y. Roskens, Chief Executive Officer

 

Subscription Agreement

6-edit_Ex10_11

		
			Exhibit 10.11
		

		
			
		

		July 24, 2016
		
			 
		

		
			Charles F. Albright, Ph.D.
		

		
			Re:  Offer of Employment
		

		
			Dear Charlie,
		

		
			On behalf of Editas Medicine, Inc. (the “Company”), I am pleased to offer you employment with the Company.  The purpose of this letter is to set forth the terms of your employment with the Company, should you accept our offer.
		

		
			I am pleased to offer you the position of Chief Scientific Officer, reporting to the Chief Executive Officer.  Your base salary will be at the rate of $15,625.00 per semi-monthly pay period (equivalent to an annualized base salary of $375,000.00).  You will be employed on a full­time basis.
		

		
			Additionally, you will be eligible to receive an annual performance bonus, targeted at 35% of your annual base salary, to be determined based on the achievement of your individual goals and the Company’s goals during the applicable fiscal year, and on a pro-rated basis.  Such bonus shall be subject to the approval of the Company’s Board of Directors (or a committee thereof).
		

		
			You must be an active employee of the Company on the date any bonus is distributed in order to be eligible for and to earn a bonus award, as it also serves as an incentive to remain employed by the Company, provided that the Company will award and pay any bonus for the prior calendar year before March 15th of the next succeeding calendar year.
		

		
			Your effective date of hire as an employee (the “Start Date”) is to be mutually agreed upon by you and the Company, but not later than September 4, 2016.
		

		
			Subject to approval of the Company’s Board of Directors, the Company will grant you a stock option to purchase an aggregate of 225,000 shares of the Company’ s common stock (the “Option”) at an exercise or purchase price equal to the fair market value of the Company’s common stock on the date of grant.  The Option will vest over four (4) years at the rate of 25% on the first anniversary of the commencement date of your employment, and an additional 2.0833% of the original number of shares at the end of each successive month following the first anniversary of the vesting commencement date until the fourth anniversary of the vesting commencement date.  The Option grant will be brought to the Board of Directors for approval after you begin employment with the Company.  The Option will be evidenced in writing by and subject to the terms of the Company’s 2015 Stock Incentive Plan (or such other plan, including
		

		
			
		

		
			

		 

			

					

						 

					

					

						 

				
	

					

						Confidential

					

					

						1

				

		

			 

		

 

		

			

		

		

		
			an inducement plan or agreement, under which such option is granted) and a stock option agreement provided by the Company.
		

		
			You will be eligible to participate in the Company’s Severance Benefits Plan, a copy of which is available at https://www.sec.gov/Archives/edgar/data/1650664/00010474691600953/4a2226902zex-10 27.htm), at the level of Other C-Level Officer (as defined in the Company’s Severance Benefits Plan).  Your eligibility under the Severance Benefits Plan is subject to the terms and conditions thereof.
		

		
			You will be eligible to participate in the Company’s Medical and Dental Insurance Programs, as well as all other Company benefits, provided you are eligible under (and subject to all provisions of) the plan documents governing those programs.  The benefit programs made available by the Company, and the rules, terms and conditions for participation in such benefit plans, may be changed by the Company at any time, in its sole discretion or as otherwise required by law, without advance notice.
		

		
			You will be eligible for a maximum of four weeks of vacation per calendar year to be taken at such times as may be approved by the Company.  The number of vacation days for which you are eligible shall accrue at the rate of 1.67 days per month that you are employed during such calendar year.  Additionally, you will receive 1 personal day and 11 paid holidays annually, in accordance with the Company holiday schedule.
		

		
			It is understood that you are an “at-will” employee.  You are not being offered employment for a definite period of time or pursuant to an employment contract, and either you or the Company may terminate the employment relationship at any time and for any reason, with or without cause or prior notice and without additional compensation to you.
		

		
			Your normal place of work will be at the offices of the Company in Cambridge, Massachusetts. Enclosed for your review is a Non-Solicitation, Non-Competition, Confidentiality and Assignment Agreement (the “Agreement”).  This offer of employment is conditioned on your willingness to sign and abide by the terms of the Agreement.  You will be expected to sign the Agreement on or prior to your Start Date.
		

		In making this offer, the Company understands, based on representations made by you, that you are not under any obligation to any former employer or any person or entity which would prevent, limit, or impair in any way your acceptance of this offer or employment or the performance by you of your duties as an employee of the Company.  In accepting this offer you represent and warrant the foregoing to be true and correct and that in connection with providing services to the Company you will not (i) use any confidential and/or proprietary information of any third party, including, without limitation, any former employer, and (ii) bring any biological or other materials to the Company.
		
			 
		

		
			The Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees.  You will  be required to complete a Form I-9 which will be provided to you before the Start Date.  Please bring the appropriate documents listed on
		

		
			
		

		
			

		 

			

					

						Confidential

					

					

						2

				

		

			 

		

 

		

			

		

		

		
			that form with you when you report for work.  We will not be able to employ you if you fail to comply with this requirement.
		

		
			This letter agreement and the Agreement referenced above constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede any prior agreements, representations or understandings (formal or informal, whether written, oral or implied) between you and the Company.  This letter agreement may not be amended or modified except by an express written agreement signed by both you and a duly authorized officer of the Company, although your job duties, title, reporting relationship, compensation and benefits may change from time to time in the Company’s sole discretion and provided that the “at-will” nature of your employment may only be changed by a written agreement signed by you and the Chief Executive Officer, which expressly states the intention to modify the at-will nature of your employment.  Nothing in this letter shall be construed as an agreement, either express or implied, to pay you any compensation or grant you any benefit beyond the end of your employment with the Company, except to the extent you are eligible for post-employment benefits under the Severance Benefit Plan.
		

		
			As an employee of the Company, you will be required to familiarize yourself and comply with all Company policies and procedures.  Violations of the Company’s policies may lead to immediate termination of your employment.  Further, the Company’s premises, including all workspaces, furniture, documents and other tangible materials, together with all information technology resources of the Company (including computers, portable devices, data and other electronic files (whether in hard copy or electronic form), and all internet and email communications) are subject to oversight and inspection by the Company at any time.  Company employees shall have no expectation of privacy with regard to any Company premises, materials, resources or information.
		

		
			Please indicate your acceptance of this offer by signing and returning the enclosed copy of this letter no later than August 1, 2016.  You may indicate your acceptance of this offer by signing on the appropriate space below and returning a signed, scanned copy along with the other necessary agreements referenced in this letter to Katrine Bosley at ksb@editasmed.com or returning by mail to Editas Medicine, Inc., 300 Third Street, Cambridge, MA 02142, Attention:  Katrine Bosley.  This offer will remain open until 5:00p.m. on August 1, 2016.
		

		
			Please know that we are truly enthused at the prospect of you becoming part of the Editas team and at your leadership helping to build what we hope will be an exceptional organization, one that is both a scientific pioneer and that delivers transformative medicines to many, many patients.  We believe that you will be a fundamental part of turning that aspiration into reality.
		

			
					
						Very truly yours,

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						/s/ Katrine Bosley

					
					
						 

					
					
						 

				
	
					
						Katrine Bosley

					
					
						 

					
					
						 

				
	
					
						Chief Executive Officer

					
					
						 

					
					
						 

				
	
					
						Editas Medicine, Inc.

					
					
						 

					
					
						 

				

		
			
		

		
			

		 

			

					

						Confidential

					

					

						3

				

		

			 

		

 

		

			

		

		

		
			 
		

			
					
						Accepted and Agreed:

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						/s/ Charles F. Albright

					
					
						 

					
					
						 

				
	
					
						Charles F. Albright, Ph.D.

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						July 26, 2016

					
					
						 

					
					
						 

				
	
					
						Date

					
					
						 

					
					
						 

				

		
			 
		

		 

			

					

						Confidential

					

					

						4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]